BMC Immunology

official impact factor 3.00

Open Access Highly Access

Comparison of human B cell activation by TLR7 and TLR9 agonists

John A Hanten*, John P Vasilakos, Christie L Riter, Lori Neys, Kenneth E Lipson, Sefik S Alkan and Woubalem Birmachu

BMC Immunology 2008, 9:39 doi:10.1186/1471-2172-9-39

Accesses  

  • Last 30 days: 208 accesses
  • Last 365 days: 2246 accesses
  • All time: 7200 accesses

Cited by

BioMed Central: 1 citation

Research article   Open Access

B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy

Diego Catalán, Octavio Aravena, Francisca Sabugo, Pamela Wurmann, Lilian Soto, Alexis M Kalergis, Miguel Cuchacovich, Juan C Aguillón, Arthritis Research & Therapy 2010, 12:R68 (15 April 2010)